Advatech Life Science Profile
Key Indicators
- Authorised Capital ₹ 7.50 Cr
- Paid Up Capital ₹ 4.75 Cr
- Company Age 14 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 6115.01%
- Profit Growth -15420.04%
- Ebitda -1524.60%
- Net Worth -14.84%
- Total Assets 11.25%
About Advatech Life Science
Advatech Life Science Private Limited (ALSPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 January 2011 and has a history of 14 years and one month. Its registered office is in Mahesana, Gujarat, India.
The Corporate was formerly known as Advatech Formulations Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.50 Cr and a paid-up capital of Rs 4.75 Cr, as per Ministry of Corporate Affairs (MCA) records.
Avesh Nandolia and Sameer Nandoliya serve as directors at the Company.
Company Details
- Location
Mahesana, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100GJ2011PTC063730
- Company No.
063730
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jan 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Advatech Life Science?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Avesh Nandolia  | Director | 22-Nov-2016 | Current |
| Sameer Nandoliya | Director | 22-Nov-2016 | Current |
Financial Performance of Advatech Life Science.
Advatech Life Science Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 6115.01% increase. The company also saw a substantial fall in profitability, with a 15420.04% decrease in profit. The company's net worth observed a substantial decline by a decrease of 14.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Advatech Life Science?
In 2023, Advatech Life Science had a promoter holding of 46.30% and a public holding of 53.70%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nanco Chem Products Private LimitedAvesh Nandolia and Sameer Nandoliya are mutual person
- Bioxis Industries Private Limited
Sameer Nandoliya is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Advatech Life Science?
Unlock and access historical data on people associated with Advatech Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Advatech Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Advatech Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
